Frederick R. Appelbaum
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 472
- Acute Myeloid Leukemia Research 306
- Hematopoietic Stem Cell Transplantation 269
- Chronic Myeloid Leukemia Treatments 79
- Multiple Myeloma Research and Treatments 40
-
- Acute Lymphoblastic Leukemia research 157
- Co-authors
- Rainer Storb (133 shared papers)Cheryl L. Willman (61 shared papers)Paul J. Martin (87 shared papers)Kenneth J. Kopecky (46 shared papers)Elihu H. Estey (78 shared papers)Marilyn L. Slovak (27 shared papers)H. Joachim Deeg (105 shared papers)Barry E. Storer (64 shared papers)
- Journals
- Blood (257 papers)Biology of Blood and Marrow Transplantation (55 papers)Journal of Clinical Oncology (34 papers)British Journal of Haematology (21 papers)Transplantation (20 papers)
- Partner nations
- United StatesSouth AfricaCanada
In The Last Decade
Frederick R. Appelbaum
592 papers receiving 41.8k citations
Frederick R. Appelbaum's Hit Papers
Peers
Comparison fields: 5 of 158
- Hematology 29.0k
- Genetics 7.7k
- Transplantation 1.1k
- Oncology 8.6k
- Public Health, Environmental and Occupational Health 8.8k
Countries citing papers authored by Frederick R. Appelbaum
This map shows the geographic impact of Frederick R. Appelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick R. Appelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick R. Appelbaum more than expected).
Fields of papers citing papers by Frederick R. Appelbaum
This network shows the impact of papers produced by Frederick R. Appelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick R. Appelbaum. The network helps show where Frederick R. Appelbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick R. Appelbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 596 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Hit paper breakdown → | 2009 | 2370 |
| 2 | Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study Hit paper breakdown → | 2000 | 1237 |
| 3 | Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation Hit paper breakdown → | 2010 | 1015 |
| 4 | Age and acute myeloid leukemia Hit paper breakdown → | 2006 | 985 |
| 5 | All-trans-Retinoic Acid in Acute Promyelocytic Leukemia Hit paper breakdown → | 1997 | 810 |
| 6 | Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia Hit paper breakdown → | 2000 | 753 |
| 7 | Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic Cancers Hit paper breakdown → | 2001 | 701 |
| 8 | Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study Hit paper breakdown → | 1997 | 697 |
| 9 | Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse Hit paper breakdown → | 2001 | 660 |
| 10 | Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Hit paper breakdown → | 2009 | 615 |
| 11 | Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support Hit paper breakdown → | 1993 | 511 |
| 12 | Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials Hit paper breakdown → | 2014 | 491 |
| 13 | 1999 | 480 | |
| 14 | A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia Hit paper breakdown → | 2013 | 464 |
| 15 | Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria Hit paper breakdown → | 2011 | 463 |
| 16 | 1998 | 446 | |
| 17 | 1998 | 420 | |
| 18 | 1991 | 397 | |
| 19 | 2005 | 325 | |
| 20 | 2001 | 323 |
About Frederick R. Appelbaum
Frederick R. Appelbaum is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Genetics and Molecular Biology, having authored 596 papers that have together received 42.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (306 papers), Hematopoietic Stem Cell Transplantation (269 papers), Acute Lymphoblastic Leukemia research (157 papers), Chronic Myeloid Leukemia Treatments (79 papers), Chronic Lymphocytic Leukemia Research (54 papers), Lymphoma Diagnosis and Treatment (46 papers), Multiple Myeloma Research and Treatments (40 papers) and Polyomavirus and related diseases (34 papers). The work is most often cited by research in Hematology (29.0k citations), Genetics (7.7k citations), Transplantation (1.1k citations), Oncology (8.6k citations) and Public Health, Environmental and Occupational Health (8.8k citations). Frederick R. Appelbaum has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Rainer Storb, Cheryl L. Willman, Paul J. Martin, Kenneth J. Kopecky, Elihu H. Estey, Marilyn L. Slovak, H. Joachim Deeg, Barry E. Storer, Richard A. Larson and David R. Head. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, British Journal of Haematology and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.